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In Brief PIEZO1 is an ion channel that converts mechanical stimuli into cellular signaling. Here, Chen et al. perform multi-species studies to define a feedforward circuit mediated by PIEZO1 and tumor tissue mechanics to promote glioma growth.
INTRODUCTION
Cells in biological tissues are exposed to mechanical forces, including hydrostatic pressure, shear stress, compressional force, and tensional force. Young's modulus (unit in force/area, N/m 2 , or Pascals, Pa) describes the amount of force required to deform a substance, and it is used to reveal stiffness reflecting tissue rigidity. In biological systems, tissue stiffness varies greatly between organs, and between healthy and disease states of the same organ. As early as the Jin Dynasty (317-420 B.C.), Chinese medical writing by Dr. Hong Ge described breast cancer as being ''hard as stone,'' highlighting that alteration of mechanical properties is a physical hallmark of solid tumors. In certain regions, solid tumor tissues are stiffer than their nontransformed counterparts due to uncontrolled cell proliferation within confined spaces, hyper-permeable blood vessels, insufficient lymphatic drainage, and increased deposition of extracellular matrix (ECM) proteins. Augmented tissue stiffness actively instructs malignant progression by regulating proliferation, invasion, apoptosis evasion, drug resistance, blood vessel formation, metabolism, and growth-promoting signaling pathways (Kai et al., 2016; Northey et al., 2017; Oudin and Weaver, 2016; Przybyla et al., 2016; Tung et al., 2015) . Glioma is the most common brain tumor and can be categorized as low to high grade (Grade I-IV), with Grade IV glioblastoma (GBM) being the most frequent and aggressive primary brain tumor in adults. The standard treatment for GBM includes surgery, chemotherapy, and irradiation, which is largely ineffective, and GBM patients face a median survival of less than 14 months. While normal brain tissue stiffness is typically lower than 200 Pa, it has been reported that human low-to highgrade gliomas (LGG and HGG) display gradual increase in tissue stiffness that ranges from 100 to 10 4 Pa (Miroshnikova et al., 2016) . In addition, the presence of fluidic and cystic tissue in tumors highlights that heterogeneous stiffness levels can develop at different tumor regions. Tumor cells sense the aberrant physical microenvironment and transduce mechanical force into intracellular signaling. Integrins are heterodimeric transmembrane protein complexes formed by a and b subunits. While the extracellular domain of integrins interacts with ECM proteins such as Collagens, Laminins, and Tenascin, their cytoplasmic domain complexes with scaffold proteins including Talin and Paxillin, and kinases such as focal adhesion kinase (FAK) and Src. These interactions allow transmission of environmental mechanical cues to control focal adhesion and cytoskeleton assembly, and activate integrin-dependent intracellular kinase signaling to regulate cell adhesion, motility, proliferation, survival, and differentiation (Kim et al., 2011) . The integrin-focal adhesion kinase signaling is hence recognized as a major mechanotransduction mechanism in tumor.
Other components of the tumor mechanosensing machinery have been identified, such as Rho family GTPases (Pajic et al., 2015) , nonmuscle myosin II (Aguilar-Cuenca et al., 2014) , and the Hippo pathway (Yu and Guan, 2013) . Modeling the altered environmental mechanics and stiffness using a hydrogel-based cell culture platform has revealed that glioma cells interact with the ECM to regulate its expression of the oncogenic microRNA miR18a (Rape et al., 2015) . The complex physical environment and varying stiffness encountered by different areas of the glioma cells can modulate their migratory capacity (Rape and Kumar, 2014) . Increased environmental stiffness can also promote glioma cell proliferation by spatially and biochemically amplifying epidermal growth factor receptor (EGFR) signaling (Umesh et al., 2014) . Furthermore, tumor tissue stiffness can be influenced by physiological state of the host, and obesity-induced interstitial fibrosis promotes breast cancer malignancy through altering mammary ECM mechanics (Seo et al., 2015) . Therefore, a large body of evidence has reported aberrant tissue mechanics and its functional impact in tumor. However, our knowledge of tumor mechanosensation and mechanotransduction remains rudimentary. Cell surface sensors and transducers that directly perceive tissue mechanics to regulate tumor aggression remain to be fully defined. The PIEZO transmembrane proteins are evolutionarily conserved ion channels that are intrinsically mechanosensitive (Murthy et al., 2017; Volkers et al., 2015; Wu et al., 2017) . Physical force-induced membrane tension opens PIEZO channel to allow permeation of cations including sodium, potassium, and calcium Lewis and Grandl, 2015) . Drosophila Piezo regulates mechanosensory nociception (Kim et al., 2012) and gut stem cell differentiation (He et al., 2018) , and its mammalian orthologs PIEZO1 and PIEZO2 convert mechanical stimuli to electrical and chemical signaling to regulate a multitude of physiological processes such as touch (Ranade et al., 2014b) , proprioception (Chesler et al., 2016; Woo et al., 2015) , respiration (Nonomura et al., 2017) , urinary osmoregulation (Martins et al., 2016) , blood flow (Li et al., 2014; Ranade et al., 2014a; Wang et al., 2016) , epithelial homeostasis (Eisenhoffer et al., 2012; Gudipaty et al., 2017) , axon growth (Koser et al., 2016) , and cardiovascular homeostasis (Rode et al., 2017) . Interestingly, PIEZO1 forms a mechanosensitive ion channel in a breast cancer cell line, while PIEZO2 was shown to regulate RhoA, actin cytoskeleton, and the motility of breast cancer cells in vitro Pardo-Pastor et al., 2018) . However, it is unknown whether and how PIEZO regulates in vivo tumorigenesis, whether tumors develop a heightened dependency on PIEZO for its malignant growth compared to non-transformed tissue, and whether the aberrant mechanical environment in tumors interplays with and hijacks the mechanosensory function of PIEZO to promote malignancy.
Here, we address these knowledge gaps by establishing multiple Drosophila models of gliomas and performing multispecies studies to define the functions of Drosophila, mouse, and human PIEZO in tumor. We discover that PIEZO channels play an evolutionarily conserved role to interact with integrin-FAK signaling to promote tissue stiffening and tumor cell proliferation. Moreover, the stiffer mechanical environment upregulates PIEZO1 expression to further elevate tumor tissue mechanosensation to aggravate glioma progression. We identify a feedforward mechanosensory circuit in which PIEZO1 iteratively interacts with glioma tissue mechanics to promote malignant progression, and propose that targeting mechanosensitive ion channel-mediated tissue stiffening may have broad applicability across different tumor types driven by distinct oncogenic mutations.
RESULTS
Establish Drosophila Models of Low-and High-Grade Gliomas with Graded Increase of Tissue Stiffness To determine how solid tumors sense and transduce tissue mechanics, we first established Drosophila glioma models that display tissue stiffening and facilitate genetic study to identify stiffness regulators in vivo. Activating genetic alterations in BRAF is common in LGGs (Penman et al., 2015) . FGFR-TACC (transforming acidic coiled-coil containing protein) gene fusions are among the most common chromosomal aberrations in human cancers, and FGFR3-TACC3 fusions were identified in 3% of GBM (Parker et al., 2013; Singh et al., 2012) . Genetic gain and mutational activation of the EGFR and phosphatidylinositol-3 kinase (PI3K) pathways is found in over 40% of GBMs (Agnihotri et al., 2013) . Using the glia cell-specific driver repoGal4 to express mRFP and constitutively active Drosophila Raf (dRaf GOF ), human FGFR3-TACC3 fusion gene (hFGFR3-hTACC3) (Frattini et al., 2018) ; mRFP + total glia cells, and aberrantly enlarged brain tissues due to glial over-growth (Figures 1A and 1B) . These tumors display increased deposition of the ECM protein Collagen IV marked by Vkg-GFP, enhanced intracellular contractility marked by Phalloidin (F actin) staining, and augmented Fak activation marked by phosphorylated Fak (Fak-pY397) (Figures 1A and 1B) . These tumor cell-autonomous and extracellular changes suggest that these gliomas may develop aberrantly increased tissue stiffness. To directly determine tissue stiffness, we performed atomic force microscopy (AFM) indentation experiments. The AFM cantilever with spherical tip was brought in contact with and indented the brain tissue. The deflection of the cantilever was reflected by the laser spot position change that was LGGs to HGGs (Miroshnikova et al., 2016) . Therefore, we established genetically tractable Drosophila models of gliomas that allow identification of molecular sensors and transducers of tissue mechanics in the tumors.
dPiezo Is Required for Proliferation and Stiffening of Drosophila Gliomas, but Not Normal Glial Tissue Drosophila Piezo (dPiezo) forms mechanosensitive cation channels in sensory neurons to perceive noxious mechanical stimulation and regulate nociception (Kim et al., 2012) , and it senses microenvironmental mechanical cues to regulate gut stem cell differentiation (He et al., 2018) . Whether dPiezo functions in oncogenically transformed cells, however, is unknown. In our Drosophila genetic study, we used multiple mutant lines. dPiezo KO refers to the global knockout for dPiezo (Kim et al., 2012 We asked whether dPiezo is required for the proliferation of non-transformed glia cells. Interestingly, dPiezo did not appear to be expressed in normal glial tissue ( Figure 2D ). In line with the lack of glial expression, dPiezo knockout had no discernible impact on the volume of glial tissue or glia cell mitosis ( Figure 2E ). Importantly, genetic deletion of dPiezo significantly reduced tissue stiffness in the three different glioma models but had no impact on stiffness of normal brains ( Figure 2F ). These findings demonstrate that Drosophila gliomas driven by various oncogenic mutations develop tumor-specific dependency on the mechanosensitive channel dPiezo to regulate tissue stiffening and malignant growth in vivo.
dPiezo Genetically Interacts with Integrin Signaling to Promote Tissue Stiffening and Glioma Aggression Next, we sought to determine the mechanism by which dPiezo regulates glioma growth. Since integrins physically interact with ECM proteins to relay mechanical cues into intracellular kinase signaling, we asked whether dPiezo-mediated signaling genetically interacts with integrin-dependent kinase signaling in the tumor. We expressed multiple components of the integrin pathway, including Drosophila a and b integrins (Mew and Mys), Paxillin, and Integrin-linked kinase (Ilk) in dPiezo-deficient gliomas. Notably, expressing the structural proteins or kinase in the integrin pathway significantly increased the numbers of mitotic glia cells and total glia cells, and rescued tumor growth in dPiezo-deficient gliomas driven by constitutively active EGFR and PI3K or the FGFR3-TACC3 fusion oncogene (Figures 3A and 3B) . Activating integrin signaling also significantly increased tissue stiffness in the dPiezo-deficient, FGFR3-TACC3-driven glioma ( Figure 3B ). Interestingly, increasing production of ECM protein from the tumor cells by expression of Drosophila Laminin A (LanA, ortholog for human Laminin A) or kkv (ortholog for human hyaluronic acid synthases that produce hyaluronic acid, a key ECM constituent) rescued the growth of tumors with dPiezo knockout ( Figure S1B ), suggesting that tissue mechanics can be sensed and transduced by molecules in addition to dPiezo. Taken together, these results show that dPiezo genetically interacts with integrin signaling to reinforce tissue stiffening and promote glioma aggression. , n = 12, 12, 12, 12 for glial tissue or tumor volume; n = 12, 12, 12, 12 for number of mitotic glia cells; n = 12, 12, 12, 12 for glia cell number; n = 17 (37 data points), 13 (29 data points), 8 (16 data points), 11 (21 data points) for Vkg-GFP volume; n = 17 (34 data points), 13 (29 data points), 8 (16 data points), 11 (21 data points) for Vkg-GFP relative intensity; n = 8 (18 data points), 8 (16 data points), 8 (14 data points), 8 (15 data points) for normalized stress fiber intensity in glial tissue or tumor; n = 7 (26 data points), 7 (28 data points), 7 (26 data points), 6 (30 data points) for pFak volume; n = 7 (26 data points), 7 (28 data points), 7 (26 data points), 6 (30 data points) for pFak relative intensity, respectively. a.u., arbitrary unit. Error bars, mean ± SEM. (C) Tissue stiffness in Drosophila gliomas and non-transformed brains measured by atomic force microscopy. The same amount of force results in less displacement in gliomas compared to non-transformed brains, revealing increased tissue stiffness in the tumors. Evolutionarily Conserved dPiezo/PIEZO1 Function in Glioma Depends on Its Ion Conductance PIEZO channels are large integral membrane proteins with more than 2,500 amino acids and at least 26 transmembrane domains (Ge et al., 2015; Saotome et al., 2018) . Given their large intracellular domains, it remains to be determined whether PIEZO function in glioma depends on their ability to conduct ions or nonconductive protein-protein interaction. To address this question, in dPiezo knockout glioma we introduced tumor-specific expression of wild-type human PIEZO1 (hPIEZO1), wild-type mouse Piezo1 (mPiezo1), a gain-of-function mouse Piezo1 (mPiezo1-TriM) in which the mutations (E2133D, D2139E, and D2144E) result in a very slowly inactivating mechanically activated current (unpublished data), and a mutant form of mouse Piezo1 (mPiezo1-2336-Myc) in which the Myc tag insertion in the last extracellular loop renders the channel non-conducting without affecting its expression or trafficking to the membrane . Importantly, we found that all but mPiezo1-2336-Myc significantly rescued glioma growth and increased tissue stiffness in gliomas with dPiezo knockout ( Figure 3C ). Expressing mPiezo1-2336-Myc further suppressed glioma growth and decreased tissue stiffness in the dPiezo knockout background ( Figure 3C ), suggesting that the non-conducting protein may affect a tumor-promoting mechanism that is parallel to dPiezo signaling. In order to confirm that mPiezo1-2336-Myc can traffic to the cell surface, we performed Myc immunostaining to determine the localization in fly glioma cells. We found that Myc signal overlaps with mCD8-GFP that marks plasma membrane (Figure S1C) . Therefore, these results demonstrate that the function of dPiezo/PIEZO1 in regulating glioma growth is evolutionarily conserved, and illustrate that the channel function of PIEZO to permeate ions is critical to glioma malignancy.
PIEZO1 Is Overexpressed in Human Gliomas, Inversely
Correlates with Patient Survival, and Regulates Tumor Growth Having established the important function of dPiezo in regulating fly glioma growth, we investigated the expression and clinical significance of its orthologs, PIEZO1 and PIEZO2, in human gliomas. We first performed ''one to all'' matrix correlation analysis in four TCGA glioma datasets containing 1,232 glioma samples to define PIEZO1-correlated genes. We calculated Pearson's correlation coefficient in 73,632 gene pairs that include PIEZO1 from the four datasets, and identified a total of 345 genes as PIEZO1 correlated (9 negatively correlated and 336 positively correlated). Next, we performed unsupervised hierarchical clustering using the TCGA GBM dataset (n = 539) and TCGA LGG-GBM dataset (n = 702). Interestingly, both datasets can be subdivided into three subgroups based on the level of PIEZO1 expression (PIEZO1 high, PIEZO1 moderate, and PIEZO1 low) (Figures 4A and S2) . Compared with normal brain tissue, all the histological subtypes of gliomas, except oligodendroglioma, show PIEZO1 overexpression ( Figures 4A and S3A ). PIEZO1 is upregulated in HGGs (WHO Grade 3 and 4) compared with
LGGs (WHO Grade 2) ( Figure 4A ), and high PIEZO1 expression tends to be associated with astrocytoma component ( Figures  4A and S3A ). IDH mutation, glioma CpG island methylator (G-CIMP) phenotype, and 1p/19q co-deletion are important molecular biomarkers that guide prognostication and treatment. Interestingly, in these four independent TCGA datasets, we found that PIEZO1 is decreased in IDH mutant gliomas including
LGGs and GBMs (Figures 4A and S3B) , and in the TCGA LGG dataset, PIEZO1 expression is elevated in 1p/19q non-co-deletion group, where it is low and high in gliomas with G-CIMP phenotype and non-G-CIMP phenotypes, respectively (Figures 4A and S3B). Next, we performed PIEZO1 immunohistochemistry using a panel of human glioma tumor tissues including
LGGs, primary GBMs, and recurrent GBMs. We found that most tumor samples displayed positive PIEZO1 expression (Figure S3C) , consistent with the fact that PIEZO1 mRNA upregulation is widespread across LGGs and GBMs ( Figure 4A ). Importantly, in this panel of tumor tissues, we detected minimal PIEZO1 protein expression in a grade II oligodendroglioma that has IDH1 mutation and 1p/19q co-deletion ( Figure S3C ). This finding further supports our bioinformatics data ( Figure 4A ).
Since the expression of PIEZO1 of IDH mutant glioma is lower than that of the IDH wild-type glioma and IDH mutation establishes a glioma hyper-methylation phenotype, we asked whether PIEZO1 promoter is hyper-methylated in IDH mutant glioma. We investigated 38 probes spanning PIEZO1 promoter in chromosome 16, and marked PIEZO1 promoter region by using chromatin immunoprecipitation sequencing (ChIP-seq) peak signal of H3K4me3 ( Figure S4A ). Markedly, we found that the DNA domain spanning PIEZO1 promoter and the upstream 8,000 bp of PIEZO1 transcription start site (TSS) are hyper-methylated in IDH mutant glioma ( Figure S4A ). Importantly, the methylation status of most of these probes negatively correlates with PIEZO1 mRNA expression ( Figure S4A ). The methylation status of regions spanning PIEZO1 promoter demonstrates significant differences between IDH mutant and IDH wild-type gliomas (Figure S4B) , and for most regions in the upstream of PIEZO1 TSS containing the promoter, IDH mutant gliomas also showed a significantly hyper-methylated phenotype ( Figure S4B ). These data suggest that the generally more aggressive IDH wild-type gliomas are epigenetically more poised to upregulate PIEZO1 at the transcription level. Consistent with our findings that high PIEZO1 expression associates with these molecular markers predictive of worse prognosis (IDH wild-type, 1p/19q non-codeletion, non-G-CIMP phenotype), Kaplan-Meier survival analysis for multiple human glioma datasets showed that patients with elevated PIEZO1 expression displayed significantly worse overall survival ( Figures 4B and S5A ). Next, we investigated whether human GBM cells display PIEZO1-dependent mechanosensitive ion channel activity. We developed a novel approach whereby our mechanical stimulation can precisely target cellular processes or cell soma, rather than the GBM cell as a whole. Given the delicate structure of cellular processes, we strategized to evoke mechanosensitive currents with brief applications of solution ejected from a glass pipette electrode under variable positive pressures, thus avoiding invasive contact with the processes and in turn maintaining their morphological structure and membrane integrity. Previous studies from the Patapoutian lab (Syeda et al., 2016) and the Gu lab (Jia et al., 2016) demonstrated PIEZO channel sensitivity to an osmotic gradient. Therefore, we performed whole-cell voltage-clamp recordings of mechanosensitive currents using both hypertonic and isotonic solutions for comparison. When brief puffs of solution were delivered under defined levels of pressure to the G532 GBM stem cells, we found that both isotonic and hypertonic solutions applied to the cellular processes reliably evoked mechanosensitive channel activity, whereas identical stimulation paradigms evoked little to no response from the soma of the same cells ( Figure 4C ). Importantly, hypertonic solution evoked significantly larger currents compared to isotonic solution ( Figure 4C ), consistent with the published studies that PIEZO channels can be modulated by osmotic gradient. The compartmentalized channel activity is reinforced by the immunostaining evidence showing PIEZO1 localization at focal adhesion sites prominently clustered at the GBM stem cell processes ( Figure 5C ). The linear I-V relationship demonstrates that the mechanosensitive current displays nonselective cation channel properties as the reversal potential is near 0 mV ( Figure S6A) . Notably, the currents were abrogated by PIEZO1 knockdown ( Figure 4C ), suggesting that PIEZO1 is one of the primary ion channels that confer mechanosensitivity to the GBM stem cells.
Next, we sought to determine whether PIEZO1 function is required for the growth of GBM cells and tumors. We used three human GBM cell lines (GS2, SF7225, and SF7881) cultured with serum, as well as three human GBM stem cell lines (G508, G532, and G411), which were established from mesenchymal GBM tumors and cultured under stem cell condition without serum (Pollard et al., 2009 ). G508 cells display amplifications in CDK4, MDM4, and EGFR, and loss of one copy of PTEN. G532 cells display amplification in PDGFRA and loss of one copy of PTEN. G411 cells display EGFR amplification. Remarkably, PIEZO1 knockdown not only ablated the cellular response to mechanical force to permeate ions, but also suppressed the clonogenic growth of GBM cell lines ( Figures 4D and 4E ). Tumor sphere formation of GBM stem cell lines was abrogated by PIEZO1 knockdown ( Figure 4F ). PIEZO1 knockdown inhibited the in vivo growth of GBM and significantly prolonged the survival of mice bearing tumors with constitutive knockdown of PIEZO1 (G532 or G411) compared to mice bearing control tumors ( Figure 4H ). Furthermore, we generated G411 GBM cells that can express PIEZO1 short hairpin RNA (shRNA) in a doxycycline-dependent manner (Figures S7A and S7B) . We treated the mice with doxycycline after tumor implantation and found that while the initial tumor growth was comparable between the control and doxycycline-treated mice, inducible PIEZO1 shRNA expression significantly suppressed GBM tumor growth and prolonged mouse survival (Figures 4G and 4H) , demonstrating that PIEZO1 is required for glioma maintenance and progression once the tumors have formed. Intriguingly, interrogation of the TCGA Pan-Cancer dataset revealed that PIEZO1 is overexpressed across multiple types of human tumors despite different tissue origins, including cancers in the brain, liver, thyroid, kidney, rectum, colon, head and neck, stomach, and prostate (Figure S5B) , suggesting that PIEZO1-mediated mechanosensation may be a general mechanism employed by solid tumors. PIEZO2 expression does not appear to enrich in specific subtypes of gliomas, and we found no correlation between PIEZO2 expression and patient survival ( Figure S6B ). Taken together, these findings show that PIEZO1 is overexpressed in the most aggressive human glioma types, and it confers both mechanosensitivity to permeate ions and growth advantage to the tumors.
PIEZO1 Localizes at Focal Adhesion to Regulate Its Assembly and Activation of Integrin Signaling
To explore the mechanisms by which PIEZO1 regulates glioma malignancy, we performed DAVID functional enrichment analysis of the human glioma datasets to annotate PIEZO1-correlated genes. Noticeably, most of the significantly enriched pathways are related to tissue stiffness, including pathways of ECM organization, collagen catabolic process, cell adhesion, integrin binding, actin cytoskeleton, focal adhesion, ECM-receptor interaction, and cellular response to mechanical stimulus ( Figures 5A  and S7C ). Importantly, most PIEZO1-correlated genes can be projected into multiple pathways, suggesting that PIEZO1 serves as a central functional node that integrates various regulators of a tissue stiffness-regulating molecular network (Figure 5B) . These bioinformatic data prompted us to ask whether PIEZO1 physically localizes to subcellular compartments in the tumor cells to facilitate its interaction with ECM and focal adhesion. Remarkably, we discovered that PIEZO1 localizes to focal adhesions where integrin and FAK are activated in the GBM stem cells ( Figure 5C ). While control cells developed at their periphery elongated focal adhesions marked by the expression of Vinculin, FAK, activated b1 integrin, and phosphorylated Paxillin (Tyr118), PIEZO1 knockdown cells failed to assemble focal adhesion structures or activate the integrin-FAK pathway ( Figures  5D-5F ). The specificity of the PIEZO1 antibody that we used was supported by RNAi-mediated ( Figures 5D and 5F ) and CRISPR-Cas9-mediated loss-of-function studies ( Figure S8A ). Interestingly, in our antibody validation experiment, after targeting exon 6 or 7 of PIEZO1 using two different guide RNAs and establishing 24 single-cell clones of the HEK293T cells, we observed that most clones displayed strong reduction of PIEZO1 protein expression ( Figure S8A ). Our finding suggests that homozygous PIEZO1 knockout may affect the growth of the HEK293T cells, and we obtained heterozygous clones with PIEZO1 deletion on one chromosome. The reduced western blotting protein band signal supports that the PIEZO1 antibody we used is specific. In addition, to demonstrate that the focal adhesion phenotypes are not secondary to compromised cell viability, we performed immunostaining experiments at an earlier time point when there was no apparent reduction in viability in the PIEZO1 knockdown cells. Under this circumstance, we still observed that PIEZO1 knockdown led to strong defects in focal adhesion assembly and activation of the integrin-FAK pathway ( Figures S8B-S8D ). These findings are consistent with the genetic interaction between dPiezo and integrin-Fak pathway in Drosophila gliomas ( Figures 3A and 3B) . Collectively, our data demonstrate that in human LGGs and HGGs, despite being driven by divergent oncogenic mutations and signaling pathways, and possibly arising from distinct brain regions, elevated PIEZO1 expression is associated with active ECM remodeling, actin cytoskeleton organization, and focal adhesion-integrin signaling. Notably, the localization of PIEZO1 at focal adhesions supports our electrophysiological data that GBM stem cells display prominent mechanosensitive ion channel activity only when their cellular processes were mechanically stimulated (Figure 4C ). This spatially segregated PIEZO1 channel activity promotes efficient assembly and signaling of focal adhesions, which serve as highly localized subcellular domains for PIEZO1 to perceive mechanical stimuli at the cell surface. With a recent study reporting that PIEZO2 channel generates calcium signals at focal adhesions to regulate stress fiber formation in a breast cancer cell line (Pardo-Pastor et al., 2018), our findings establish focal adhesions as central hubs where physical localization of PIEZO channels senses and integrates mechanical cues to regulate intracellular signaling in diverse cell types.
A Reciprocal PIEZO1-Dependent Feedforward Mechanism between Tissue Stiffening and Tumor Mechanotransduction
To unequivocally establish PIEZO1 as the key regulator that senses microenvironmental stiffness and transduces the mechanical cue into growth-promoting signal, we cultured GBM stem cells in polyacrylamide hydrogels of various levels of stiffness (100-5,000 Pa), which encompass the stiffness range from normal human brain, LGGs to HGGs. The percentage of GBM stem cells undergoing active cell cycling and the total number of cells increased with stiffness. However, PIEZO1 knockdown abrogated this stiffness-dependent tumor cell growth (Figures 6A-6D ). Unexpectedly, we found that both the mRNA and protein levels of PIEZO1 were upregulated by the increased environmental stiffness ( Figures 6E and 6F ). Next, we decided to determine the effect of activating the ion channel activity of endogenous PIEZO1 by treating GBM cells with a specific PIEZO1 agonist (Yoda1). We found that the GBM cells displayed comparable growth with or without Yoda1 treatment at all tested stiffness levels ( Figure S8E ), suggesting that while endogenous PIEZO1 is necessary for GBM cell growth, further increasing its channel activity is not sufficient to promote malignancy in the tested cell culture condition. To identify PIEZO1 target genes with high confidence, we performed RNA sequencing of two GBM stem cell lines (G508 and G532) with and without PIEZO1 knockdown and found that multiple pathways, such as those in mitotic cell cycle, focal adhesion, ECM, and response to mechanical stimulus, were altered ( Figures 6G and S9) . We performed computational analysis to identify the common genes detected both as PIEZO1-correlated genes from TCGA datasets and altered genes after PIEZO1 knockdown from these two GBM stem cell lines. Strikingly, this unbiased, large-scale bioinformatics interrogation of both human tumor datasets and differential gene expression after PIEZO1 knockdown in glioma cells revealed a total of nine genes as high-confidence PIEZO1 target genes ( Figure 6H ). Among them, four genes (PLOD1, MMP14, ADAM9, and PLAU) are known to control ECM remodeling, FHL3 controls actin cytoskeleton, and TAZ regulates the mechanosensitive HIPPO signaling pathway ( Figure 6I ). Taken together, these data suggest that PIEZO1 not only relays mechanical input to promote glioma growth, but also actively modulates ECM and other mechanotransduction mechanisms in the tumor.
DISCUSSION
The interplay between physical forces and biochemical signaling pathways controls tumor initiation and progression. Although the impact of force on tumor malignancy was described several decades ago, the molecules that detect mechanical input and transduce physical force into intracellular signaling have yet to be fully identified. While PIEZO channel-mediated mechanotransduction is critical for many physiological sensory functions such as touch and proprioception, we report here a previously unrecognized in vivo role of PIEZO to promote tumor aggression by increasing tissue stiffening, a physical feature of solid tumors. Mouse Piezo1 and human PIEZO1 can rescue the glioma growth defect caused by genetic knockout of endogenous Drosophila Piezo, highlighting that the PIEZO class of mechanosensitive ion channels has evolutionarily conserved function in tumors. The fact that Drosophila Piezo regulates gliomas driven by highly distinct oncogenic mutations and signaling pathways, and that PIEZO1 is overexpressed across multiple types of human solid tumors, suggests that PIEZO-mediated mechanosensation and signaling may serve as a general mechanism for tumors to perceive and respond to their aberrant tissue mechanics. Tumor tissue stiffening provides a mechanical microenvironment to activate PIEZO1, the activity of which promotes the assembly of focal adhesions and activates integrin-FAK signaling. PIEZO1 signaling regulates proliferation and the expression of genes involved in ECM remodeling, which can further modulate tissue stiffness. In turn, the stiffer environment upregulates PIEZO1 expression to increase the mechanosensory and mechanotransduction capacity of the tumor cells. Therefore, glioma cells are mechanosensory and these processes form a reciprocal, disease-aggravating feedforward circuit between PIEZO1-dependent mechanotransduction and aberrant tissue mechanics in gliomas (Figure 7) . A dual role for PIEZO1 has been reported in regulating tissue homeostasis. PIEZO1 promotes live-cell extrusion in overcrowded epithelial tissue, providing a potential tumor-suppressive mechanism (Eisenhoffer et al., 2012) . PIEZO1 activity also stimulates a proliferative response to increase cell density when tissue stretching or wounding results in a sparse cell distribution (Gudipaty et al., 2017 ). Our findings demonstrate that this cell contact-dependent, balanced PIEZO1 function is lost upon tumorigenesis, and oncogenically transformed cells, which resist contact inhibition and densely populate the tumor tissue, rewire the mechanosensory function of PIEZO1 to unidirectionally promote malignant progression.
Our bioinformatics study identified that PIEZO1 promoter is generally hyper-methylated in the IDH mutant gliomas, and this correlates with decreased PIEZO1 mRNA expression in these tumors. This finding suggests that the generally more aggressive IDH wild-type gliomas are epigenetically more poised to overexpress PIEZO1. Whether various growth factor signaling pathways that are active in the IDH wild-type glioma subtypes further upregulate PIEZO1 expression is an interesting topic that warrants future investigation. Since aggressive gliomas markedly overexpress PIEZO1, tumor-specific pharmacological inhibition of PIEZO1 may demonstrate therapeutic efficacy. Currently identified inhibitors, such as ruthenium red, Gd 3+ , or the spider peptide toxin GsMTx4, are not PIEZO1 specific and act on a variety of ion channels that have mechanosensitive properties. Recent high-throughput screenings identified three small molecule chemical activators of PIEZO1, Yoda1, Jedi1, and Jedi2 (Syeda et al., 2015; Wang et al., 2018) , which affect PIEZO1 channel activity by regulating its sensitivity or inactivation kinetics of mechanically induced responses, suggesting that PIEZO1 is amenable to pharmacological modulations. Interestingly, these compounds display no discernible impact on PIEZO2. As high-resolution structure of PIEZO1 recently became available (Saotome et al., 2018; Zhao et al., 2018) , rationally designed compound screening should facilitate the development of highly specific pharmacological modulators of PIEZO1 as novel therapeutics. PIEZO1 and PIEZO2 are expressed in different organs and each in general regulates a distinct set of physiological functions. For example, PIEZO1 controls vascular homeostasis (Li et al., 2014; Ranade et al., 2014a) , blood pressure (Wang et al., 2016) , and axon growth (Koser et al., 2016) , while PIEZO2 functions in mediating touch (Ranade et al., 2014b ), proprioception (Woo et al., 2015 , airway stretch, and lung inflation (Nonomura et al., 2017) . Although we found that PIEZO2 expression is not prognostic in glioma, PIEZO2 was recently shown to regulate breast cancer cell migration in vitro (Pardo-Pastor et al., 2018) . Future experiments using animal models to examine the in vivo function of PIEZO2 and assess the therapeutic potential to target PIEZO2 in cancer are warranted.
Brain tumors, like many other types of solid tumors, display considerable levels of genetic and cellular heterogeneity. For example, brain tumors can be categorized into distinct subtypes based on mutational signatures and major signaling pathways that regulate tumor initiation, maintenance, or progression (Cavalli et al., 2017; Huse et al., 2013; Verhaak et al., 2010) . It is striking that high PIEZO1 expression is not associated with a specific glioma subtype, and its overexpression is found in LGGs or HGGs with worse prognosis caused by a variety of genetic alterations. We suggest that this association between PIEZO1 expression and the aggressive glioma phenotype is consistent with the increasing tissue stiffening as tumorigenesis proceeds, and PIEZO1 upregulation and function amplify the level and speed of tissue stiffening to aggravate disease progression. PIEZO1 function in glioma may be conserved in other types of human cancers that overexpress PIEZO1, and our findings may stimulate evaluation of the potential to target other types of mechanosensitive ion channels in cancer. In addition to genetic heterogeneity, brain tumors consist of a hierarchy of cell types. Situated at the apex of tumor cellular hierarchy, brain During disease progression, tumor tissue stiffening provides a favored mechanical microenvironment to activate PIEZO1, which localizes at various tumor cell regions including focal adhesion. PIEZO1 regulates the assembly of focal adhesions, activation of integrin-focal adhesion signaling, tumor cell proliferation, and the expression of a number of genes involved in ECM remodeling. In addition, tissue stiffening in the tumor further increases the mRNA and protein level of PIEZO1, which in turn elevates the mechanosensory and mechanotransduction capacity of the tumor cells. These processes form a reciprocal, feedforward circuit between tumor cell mechanotransduction and aberrant tissue mechanics in gliomas to promote malignancy.
tumor-initiating cells (BTICs) are rare tumor cells that give rise to both transiently proliferative and differentiated tumor cells. BTICs resist conventional anti-mitotic therapy that targets only rapidly dividing cells; hence, they are the root for tumor initiation and recurrence. It would be of both scientific and clinical significance to determine whether various tumor cell types display different dependencies on physical cues provided by their microenvironment, and define tumor cell-type-specific mechanosensation and mechanotransduction mechanisms.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Drosophila stocks Please refer to Table S1 for the Drosophila stocks used in this study.
Drosophila study All larvae and flies were kept at 25 C unless otherwise specified. For experiments to study components of the integrin pathway (Figures 3A and 3B) and ECM rescue ( Figure S1B ) in dPiezo-deficient gliomas, room temperature (22 C) was used. Randomly selected male and female larvae at the late third instar stage were studied.
Patient samples and cell culture All samples were obtained following informed consent from patients. All experimental procedures were performed in accordance with the Research Ethics Board at The Hospital for Sick Children (Toronto, Canada). Approval to pathological data was obtained from the respective institutional review boards. Out of 8 patient samples, 3 were female and 5 were male, and ranged from 25-to 78-years of age. GS2, SF7225 and SF7881 GBM cell lines were cultured using DMEM with 10% FBS. GS2 cells have RB loss with methylated MGMT promoter. SF7225 cells have PDGFR amplification, p16 loss and unmethylated MGMT promoter. G508, G532 and G411 GBM stem cell lines, which were established from mesenchymal GBM tumors, were cultured using serum-free NS cell self-renewal media (NS media) consisted of Neurocult NS-A Basal media, supplemented with 2 mmol/L L-glutamine, hormone mix (in house equivalent to N2), B27 supplements, 75 mg/mL BSA, 2 mg/mL Heparin, 10 ng/mL basic FGF and 10 ng/mL human EGF. G508 cells display amplifications in CDK4, MDM4, EGFR, and loss of one copy of PTEN. G532 cells display amplification in PDGFRA and loss of one copy of PTEN. G411 cells display EGFR amplification, GBM stem cell lines were grown adherently on culture plates coated with poly-L-ornithine and laminin. All cell lines were regularly checked for mycoplasma infections and treated with Plasmocin (Invivogen) when infection was noted. No cell lines are listed in the database of commonly misidentified cell lines maintained by ICLAC and NCBI Biosample.
Mice
Eight weeks-old female NOD scid gamma /J#5557 immunodeficient mice were used for xenograft experiments. The mice were housed under aseptic conditions, which included filtered air and sterilized food, water, bedding, and cages. Age-matched mice with the same sex (female) were randomly assigned to experimental groups. All mice were subjected to stereotactic implantation of GBM stem cells. In the DOX treatment experiment, half of transplanted mice were fed with rodent diet containing 625 mg per kg of DOX which is estimated to provide 1.6-2.7 mg of DOX daily based on a 3-5 g diet. There were no specific inclusion or exclusion criteria. All procedures involving animals were performed in compliance with the Animals for Research Act of Ontario and the Guidelines of the Canadian Council on Animal Care. The Centre for Phenogenomics (TCP) Animal Care Committee reviewed and approved all procedures conducted on animals at TCP (protocol 19-0288H).
METHOD DETAILS
Drosophila immunostaining, confocal microscopy and image quantifications 3 rd instar larvae were dissected in PBS, fixed in 4% formaldehyde for 20 min at room temperature, incubated with primary antibody overnight at 4 C and secondary antibody for 2 hours at room temperature. Generating cell culture coverslips with various levels of stiffness, cell counting, self-renewal assay and immunofluorescence staining Polyacrylamide (PA) gel substrates with different stiffness were fabricated on glass coverslips. Briefly, PA gel solutions were prepared by varying the concentration of acrylamide (3%-5%, Bio-Rad) and bis-acrylamide (0.01%-0.15%, Bio-Rad) in deionized water. Polymerization was initiated with 0.05% ammonium persulfate (Sigma) and 0.1% N,N,N',N'-Tetramethylethylenediamine (TEMED, Sigma). 15 ml of each final solution was pipetted onto the glass coverslips treated with 0.5% 3-aminopropyltrimethoxysilane (Sigma) and 1% glutaraldehyde (Sigma). To cross-link extracellular matrix protein onto PA gel surface, the gels were photoactivated by sulfo-SANPAH (Sigma) under UV light (10 min). Subsequently, gels were incubated in 200 mg/mL laminin solution (Sigma) at 37 C for 4 hours, followed by rinsing in phosphate buffered saline (PBS) and UV sterilization for 30 min. The Young's modulus (100 Pa, 500 Pa, 1 KPa or 5 KPa) of PA gels was quantified by AFM. For the cell counting experiment, same numbers of cells (10 5 in each well of 6-well plate) were seeded for both the control and PIEZO1 knockdown groups at various stiffness conditions. From day 0 (seeding day) to day 6, images were acquired by the Nikon DS-L3 camera connected to a Nikon Eclipse TS100 inverted microscope with 10X objective lens. Cell numbers were quantified in five randomly selected imaging fields in three biological replicates. The specific PIEZO1 agonist Yoda1 was used at the concentration of 5 mM to activate the ion channel activity of endogenous PIEZO1.
To determine the clonogenic potential of GBM cells, cells were plated at clonal density (150 cells/mL of culture medium) into 60 mm plates. Cell colonies were stained with 0.05% crystal violet 7-10 days after seeding. Representative results from three independent experiments were shown for all clonogenic assays. For cell counting study, GBM stem cells were cultured adherently and in triplicates in 24-well plates. The cells were digested by Accutase for 5 min at 37 C, and the numbers of live cells were counted using Trypan Blue dye exclusion assay with Haemocytometer. Cell numbers were quantified by averaging the three biological replicates for each time point from day 2 to day 8. To perform stem cell sphere formation assay, GBM stem cells were plated in serial dilutions (ranging from 2000 to 3 cells per well) on non-adherent 96-well plates in six biological replicates. One week after plating, the numbers of wells with spheres were quantified and the data were analyzed by the Extreme Limiting Dilution Analysis (ELDA) software, which calculates the frequency of sphere forming cells and the differences between groups using the Chi-square test.
To perform immunofluorescence staining, GBM cells were fixed in 4% formaldehyde for 20 min at room temperature, incubated with primary antibody overnight at 4 C and secondary antibody for 2 hours at room temperature. The primary antibodies used were rabbit anti-PIEZO1 (1:400, Proteintech), mouse anti-activated b1 integrin (1:500, Abcam), mouse anti-Vinculin (1:1000, Millipore), mouse anti-FAK (1:400, BD Biosciences), mouse anti-Paxillin (1:400, BD Biosciences), and rabbit anti-phosphorylated Paxillin (Tyr118) (1:500, Invitrogen), and rabbit anti-Ki67 (1:3000, Abcam). Secondary antibodies conjugated to Alexa Fluor 488 or 546 (Invitrogen) were used at 1:1000. Images were acquired with Leica SP8 confocal microscope. The fluorescence intensity and size of focal adhesion and integrin-FAK signaling molecules were quantified by Volocity software. The intensity and puncta size of PIEZO1 at focal adhesion were quantified by PIEZO1 puncta signal at the site of focal adhesion molecules marked by b1 integrin.
Patient tissue staining and Microscopy
Tissue samples were fixed for 24 hours with PFA, paraffin embedded and serial sectioned. Sections were deparaffinized and rehydrated through an alcohol gradient to water for antigen retrieval in 10 mM citrate buffer PH 6.0 in a rice cooker. The rabbit anti-PIEZO1 antibody (1:200, Proteintech) was incubated overnight at 4 C, the anti-rabbit HRP step was done with 30-min incubation at room temperature. The DAB color reaction was developed at room temperature and stopped after 1 min. The slides were then counterstained with Hematoxylin. Tissue sections were imaged using 3DHistech Pannoramic 250 Flash II Slide Scanner.
Real-Time Quantitative PCR Total RNA from cells was isolated using PureLinkTM RNA mini kit according to manufacturer's protocol (Thermo Fisher Scientific). cDNAs were synthesized with the Tetro reverse transcriptase (Bioline). Real-time PCR was performed using the following specific human primers: PIEZO1 (forward: CTCTTCCTGGCGCTGTTC; reverse: GATGAGGTTGGTGGAGTTGG); ACTB (forward: AGAGC TACGAGCTGCCTGAC; reverse: AGCACTGTGTTGGCGTACAG); GAPDH (forward, CTCCTGCACCACCAACTGCT; reverse, GGGCCATCCACAGTCTTCTG). ACTB and GAPDH were used as internal controls for gene expression quantification. Real-time PCR was performed with ABI Viia7 using SYBR green PCR master mix. Relative mRNA abundance was done using the DDCT method (in triplicates). Each experiment was performed in three biological replicates.
Lentivirus-mediated shRNA study Human pLKO.1 lentiviral shRNA target gene set against PIEZO1 and pLKO.1-TRC-control vector were obtained from Dharmacon. Virus infections were performed within antibiotics-free culture medium for 24 hours. PIEZO1 shRNA mature antisense sequences are: #1: ATGATTGTACTTCTTGGTGAG; #2: TTCCACCTGAATGTGGTCTTC.
Human pTRIPZ inducible lentiviral shRNA target gene set against PIEZO1 vector were obtained from Dharmacon. Cells infected by virus were selected by Puromycin for 1 week. Cells were also screened for infection efficiency by calculating RFP positive cells after doxycycline induction. More than 95% of cells were infected. PIEZO1 shRNA mature antisense sequences are: #1: TCTTCTCTGTCTCTCGGCT; #2: TGATGAAGTACTTGAGGCA.
Xenograft and in vivo bioluminescence imaging
Tumor cells with firefly-luciferase-expressing reporter GBM cells were transduced with a lentiviral vector pBMN (CMV-copGFP-Luc2-Puro, Addgene plasmid #80389, a gift from Magnus Essand) containing GFP and firefly luciferase under the control of the cytomegalovirus (CMV) promoter. Cells were screened for infection efficiency by calculating GFP positive cells and by treatment with luciferin (D-luciferin potassium salt, Gold Biotechnology, St Louis, MO) in vitro and examination by the Xenogen IVIS Lumina System. More than 95% of cells were infected. Surgical procedure for implantation of tumor cells Eight weeks-old female NOD scid gamma /J#5557 immunodeficient mice were anesthetized using gaseous isoflurane and immobilized in a stereotaxic head frame. The skull of the mouse was exposed and a small opening was made using sterile dental drill (Precision Guide) at 2 mm lateral and 1 mm posterior to bregma. At this location, 10 5 G532 or G411 cells in 2 mL Hanks' Balanced Salt Solution without Ca 2+ and Mg 2+ (HBSS) was slowly injected (over 3 min) 2.5 mm deep to the surface of the skull using a Hamilton syringe. All procedures were carried out under sterile conditions. In vivo bioluminescence monitoring In vivo bioluminescence imaging was performed using the Xenogen IVIS Lumina System coupled LivingImage software for data acquisition. Mice were anesthetized using gaseous isoflurane and imaged 10 min after intraperitoneal injection of luciferin. Signal intensity was quantified within a region of interest over the head defined by the LivingImage software.
Bioinformatics study Datasets and Data processing TCGA AffyU133a gene expression array data and IlluminaHiSeq RNA-seq data of LGGs and GBMs were downloaded from https:// tcga-data.nci.nih.gov/via Xena Browser developed by UCSC. Clinical information and data of molecular biomarkers (IDH mutation, 1p/19q co-deletion, G-CIMP phenotype, MGMT promoter methylation and molecular subtype) were generated from TCGA publications. The clinical information and gene expression datasets of GEO: GSE16011, GSE4290, GSE4412, GSE43107 and GSE43378 were acquired from Gene Expression Omnibus (GEO). For GEO microarray datasets, background subtraction, normalization and expression summarization of raw CEL files were performed using the Robust Mult-array Average (RMA) algorithm in R and the Bioconductor package affy. Determining PIEZO1 correlated genes The TCGA LGG-GBM RNA-seq dataset, TCGA LGG RNA-seq dataset, TCGA GBM RNA-seq dataset and TCGA u133a GBM dataset were processed to determine PIEZO1 correlated genes. R package psych was used to calculated matrix correlations and probability of all the gene pairs in each dataset. Gene pairs with r value > 0.3 and False Discovery Rate (FDR) value < 0.05 were identified as significantly correlated. PIEZO1 significantly correlated genes from each dataset were intersected according to correlation direction independently and the results were generated and visualized via a Venn diagram plotted by using the VENNY2.1 tool (http:// bioinfogp.cnb.csic.es/tools/venny/). We regained matrixes of PIEZO1-related genes from 529 GBM (GBM u133a microarray) and 702 glioma (LGG-GBM RNA-seq). The hierarchical clustering with agglomerative average linkage targeting the new matrices was performed using the R/ConsensusClusterPlus package.
Enrichment Analysis
For PIEZO1 correlated genes, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed using the DAVID 6.8 online tool. Background selection and gene list conversion were conducted. The molecular network of PIEZO1 correlated genes and enriched pathways were generated using Cytoscape 3.6.1. Survival Analysis R package survival was used for overall survival analysis. Medians of PIEZO1 expression in each dataset were used as primary cut-off point for log-rank test. For those datasets that can not be evaluated by PIEZO1 medians, we used the widely accepted method, cutoff finder, to optimize the cutoff points. Cox proportional hazard (PH) model is executed by the function Coxph and Survfit from R packages. The best-scanned cutoff points are defined as the one with the most significant (log-rank test) split.
RNA-seq analysis
Transcript-level expression analysis of RNA-seq experiments was conducted following the ''new Tuxedo'' protocol established by Mihaela Pertea et al. HISAT2 was used for read alignments. StringTie was used for transcripts assembly and quantification. R package Ballgown was used for differential gene expression analysis. Differentially expressed genes with FDR < 0.05 and fold change > 2 (or < 0.5) were accepted as significant.
4%-12% Bis-Tris gel (Invitrogen #NW04125BOX) at 200 V for 20 min with MES running buffer. The proteins were then transferred onto PVDF membrane (Millipore #IPVH0001) and blocked with 5% BSA and 0.1% Tween-20 in TBS. Western blot assays were performed using primary antibodies diluted in the blocking solution. Immunoreactive bands were visualized using Bio-Rad Chemidoc imaging system and analyzed using ImageJ software. The primary antibodies used were: rabbit anti-Piezo1 (Proteintech #15939-1-AP, 1:1000), mouse anti-FAK (BD Biosciences #610088, 1:1000), rabbit anti-pFAK (Tyr397) (Thermo Fisher #44624G, 1:1000), mouse anti-atubulin (Sigma Aldrich, 1:5000), rabbit anti-GAPDH (New England Biolabs, 1:5000). Each experiment was performed in three or four biological replicates.
Generation of PIEZO1 deficient HEK293T clones CRISPR-Cas9 mediated genome editing was used to generate PIEZO1 deficient HEK293T clones. Guide RNA 5 0 -GTGCAAG CAGTGTTACGGCC-3 0 and 5 0 -AGCAGACTCTGCGTCGCGGT-3 0 , targeting exon 6 and exon 7 of PIEZO1, respectively, were cloned into pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene plasmid #42230, a gift from Feng Zhang). HEK293T cells were co-transfected in T25 flasks using 15 mg of pX330 plasmid and 15 mg of pBMN plasmid in 1.5mL of OptiMEM (Life Technologies), combined with 40 mL PolyEZ (BioMart) in 1.5 mL of OptiMEM. 3 days after transfection, single fluorescent cells were sorted into 96 well plates containing DMEM 10% FBS media using SH800 Cell Sorter (Sony Biotechnology). 12 colonies of each guide RNA transfected HEK293T cells were collected and PIEZO1 expression was assayed using western blot.
Electrophysiology G532 GBM stem cells were seeded on laminin (5 mg/mL overnight at 37 C)-coated plastic coverslips for 48-72 hours. Coverslips were transferred to a continuously perfused recording chamber. The perfusion solution consisted of (in mM) 140 NaCl, 5 KCl, 1.2 CaCl 2 , 0.5 MgCl 2 , 5 glucose, and 10 HEPES (pH adjusted to 7.3 with NaOH). Patch pipettes for recording, with resistance of 2-3 MU, were filled with intracellular solution consisting of (in mM) 140 CsCl, 1 EGTA, 10 HEPES, 4 ATP, and 0.1 GTP (pH adjusted to 7.3 with CsOH). Whole-cell currents at -80 mV were recorded using an Axopatch 700B amplifier (Molecular Devices). Pipettes for focal mechanical stimulation, with resistance of 0.7-1.5 MU, were filled with the extracellular-like solution consisting of (in mM) 130 NaCl, 10 HEPES, 10 TEA-Cl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 (pH adjusted to 7.3 with NaOH) with 300 sucrose (hypertonic solution) or without 300 sucrose (isotonic solution). The hypertonic high sucrose jet stream to the processes of the cell was used to evoke mechanosensitive currents via osmotic pressure-induced stretch of the cell membrane. 100 ms steps of positive pressure from 0 to 100 mmHg in 50 mmHg increments were applied to the stimulation electrode via Clampex-controlled high-speed pressure clamp system (HSPC-1; ALA-Scientific). The stimulation pipette was placed < 10 mm from the stimulation site on the cell. 60 s inter-sweepintervals allowed for recovery of any prolonged desensitized mechanically activated channels. A square glass perfusion barrel (0.4 mm in width) was positioned to deliver extracellular solution in the direction of the cell to ensure the pressure-driven hypertonic solution application could not accumulate around the cell. All experiments were performed at room temperature.
Data were acquired online, filtered at 4 kHz, digitized at 50 kHz, and analyzed offline using pClamp9 software (Molecular Devices). Analysis of mechanically activated currents by fold change was performed using peak currents from the onset of the pressure step to 1.0 s to account for any late or secondary currents. Quantified data were graphed using GraphPad Prism.
QUANTIFICATION AND STATISTICAL ANALYSIS
No statistical methods were used to pre-determine sample sizes. The statistical analyses were done afterward without interim data analysis. No data points were excluded. Two-tailed Student's t test was performed for comparison between two groups of samples. Two-Way ANOVA analyses were used to assess significance of multiple data points. The Kaplan-Meier estimator and GraphPad Prism software were used to generate survival curves. Differences between survival curves were calculated using a log-rank test. Data distribution was assumed to be normal but this was not formally tested. All data were collected and processed randomly. Each experiment was successfully reproduced at least three times and was performed on different days. The exact values of ''n'' (sample size) and the numbers of data points are provided in the figures and figure legends. All data are expressed as mean ± SEM. We considered a P value less than 0.05 to be statistically significant.
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